Education
About Us
Working with TipRanks
Follow Us
Ironwood Pharma (IRWD)
NASDAQ:IRWD
IRWD Analyst Ratings
Hold
0 Buy
6 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
IRWD Stock 12 Month Forecast
Average Price Target
$0.85
▲(39.34%Upside)
| Highest Price Target$1.00 | Average Price Target$0.85 | Lowest Price Target$0.70 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$0.5
Sell
-18.03%
Downside
Downgraded
06/06/25
Ironwood Pharma's overall stock score is primarily driven by financial performance challenges, including negative equity and declining revenues, compounded by bearish technical indicators. The negative corporate event related to the Nasdaq deficiency letter further heightens risk. The lack of earnings call insights and poor valuation metrics contribute to the low score.
Leerink Partners
$1
Hold
63.93%
Upside
Reiterated
05/07/25
Craig-Hallum
―
Hold
―
Reiterated
05/07/25
Wells Fargo
$1
Hold
63.93%
Upside
Reiterated
04/30/25
Jefferies
$0.7
Hold
14.75%
Upside
Downgraded
04/15/25
UBS
$8→$0.7
Hold
14.75%
Upside
Downgraded
04/14/25
Citizens JMP
―
Hold
―
Downgraded
04/14/25
Capital One Financial
$5
Hold
719.67%
Upside
Assigned
10/03/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$0.5
Sell
-18.03%
Downside
Downgraded
06/06/25
Ironwood Pharma's overall stock score is primarily driven by financial performance challenges, including negative equity and declining revenues, compounded by bearish technical indicators. The negative corporate event related to the Nasdaq deficiency letter further heightens risk. The lack of earnings call insights and poor valuation metrics contribute to the low score.
Leerink Partners
$1
Hold
63.93%
Upside
Reiterated
05/07/25
Craig-Hallum
―
Hold
―
Reiterated
05/07/25
Wells Fargo
$1
Hold
63.93%
Upside
Reiterated
04/30/25
Jefferies
$0.7
Hold
14.75%
Upside
Downgraded
04/15/25
UBS
$8→$0.7
Hold
14.75%
Upside
Downgraded
04/14/25
Citizens JMP
―
Hold
―
Downgraded
04/14/25
Capital One Financial
$5
Hold
719.67%
Upside
Assigned
10/03/24
Best Analysts Covering Ironwood Pharma
1 Month
xxx
Success Rate
1/7 ratings generated profit
Average Return
-9.59%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 14.29% of your transactions generating a profit, with an average return of -9.59% per trade.
3 Months
xxx
Success Rate
2/7 ratings generated profit
Average Return
-11.87%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 28.57% of your transactions generating a profit, with an average return of -11.87% per trade.
1 Year
Success Rate
0/7 ratings generated profit
Average Return
-57.99%
reiterated a buy rating a year ago
Copying David Amsellem's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -57.99% per trade.
2 Years
xxx
Success Rate
0/7 ratings generated profit
Average Return
-83.96%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -83.96% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
IRWD Analyst Recommendation Trends
Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
7
8
7
3
1
Buy
3
4
4
4
2
Hold
4
4
3
11
12
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
16
14
18
15
Each month's total comprises the sum of three months' worth of ratings.
IRWD Financial Forecast
IRWD Stock Forecast FAQ
What is IRWD’s average 12-month price target, according to analysts?
Based on analyst ratings, Ironwood Pharma’s 12-month average price target is 0.85.
What is IRWD’s upside potential, based on the analysts’ average price target?
Ironwood Pharma has 39.34% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is IRWD a Buy, Sell or Hold?
Ironwood Pharma has a consensus rating of Hold which is based on 0 buy ratings, 6 hold ratings and 0 sell ratings.
What is Ironwood Pharma’s price target?
The average price target for Ironwood Pharma is 0.85. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1.00 ,the lowest forecast is $0.70. The average price target represents 39.34% Increase from the current price of $0.61.
The highest analyst price target is $1.00 ,the lowest forecast is $0.70. The average price target represents 39.34% Increase from the current price of $0.61.
What do analysts say about Ironwood Pharma?
Ironwood Pharma’s analyst rating consensus is a Hold. This is based on the ratings of 6 Wall Streets Analysts.
How can I buy shares of IRWD?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.